Type
Business expansion
Country
Germany
Region
Sachsen-Anhalt; Halle; Halle/Saale
Location of affected unit(s)
Halle
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Chemicals And Chemical Products
20 - Manufacture Of Chemicals And Chemical Products

100 jobs
Number of planned job creations
Job creation
Announcement Date
3 June 2024
Employment effect (start)
3 June 2024
Foreseen end date
3 June 2024

Description

The German chemical company Wacker Biotech, a subsidiary of Wacker Chemie, has officially opened a new mRNA competence centre at its site in Halle (Saale), Saxony-Anhalt, creating 100 new jobs.

The background to this is the construction of a new mRNA competence centre, in which the company has invested over €100 million. The new facility can produce active ingredients based on messenger ribonucleic acid (mRNA) on a large scale. Over 100 highly qualified jobs are created at the centre as a result.

Wacker Chemie has around 16,400 employees at 27 production sites and 48 sales offices worldwide and annual sales of around €6.40 billion in 2023. In 2023, Wacker has also created 100 new jobs in Bavaria Wacker Chemie - 2023 - DE.


Sources

Citation

Eurofound (2024), Wacker Biotech, Business expansion in Germany, factsheet number 201271, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/201271.